Avia Pharma – is a nordic pharmaceutical company & was founded by a group of senior executives. Avia Pharma will grow significantly through both acquisitions and in licensing of products. We strive to create value for all stakeholders, owners, customers and the society. We are a fast growing and innovative company with a robust and sustainable business model. Our goal – is to become the market leader in selected therapeutic areas with prescription and otc products.
2021-03-25: Avia Pharma acquires Libragel
2020-08-03: Avia Pharma continues to expand – acquires Pharmaprim
2020-01-01: Avia Pharma acquires two skin products from Perrigo
2019-06-07: Avia Pharma signs licence agreement for Viiral
2019-01-05: Avia Pharma signs license agreement for Femarelle
2018-02-05: Long term license agreement signed for Intrarosa®
2018-02-01: Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology